Rigel Pharmaceuticals, Inc.RIGLNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 57% recommend buying.

Consensus Rating

Buy

14 analysts·Moderate coverage

57%

Rating Distribution

Strong Buy

00%

Buy

857%

Hold

643%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 11% higher.

Bear Case

$38.00

+6%

Consensus

$40.00

+11%

Bull Case

$42.00

+17%

Price Range14 analysts

Low

Consensus

High

$38.00

$42.00

Current Target

Current Price

$35.91

Upside to Target

$4.09

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$3.75(3 analysts)

P/E6x

Current: 5.7x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+14.32%

EPS+21.54%

FY2028

Rev+13.67%

EPS-7.90%

FY2029

Rev+0.33%

EPS+8.98%

Earnings Surprises

Beat rate:92%(11/12 quarters)

Avg surprise:+171.4%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Nov 5, 2025Jefferies

Rigel Pharmaceuticals upgraded to Buy from Hold at Jefferies

Target:$42.00

+11.0%from $37.85

Nov 5, 2025Cantor Fitzgerald

Rigel Pharmaceuticals price target raised to $38 from $32 at Cantor Fitzgerald

Target:$38.00

+1.0%from $37.63

Aug 17, 2022Piper Sandler

Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $2

Target:$2.00

+28.2%from $1.56

Jun 8, 2022Jefferies

Rigel Pharmaceuticals downgraded to Hold from Buy at Jefferies

Target:$1.00

+41.0%from $0.71

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance